Stress Biomarkers:Attaching Biological Meaning to Field Friendly Salivary Measures
NCT01673087 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 256
Last updated 2018-04-23
Summary
Cortisol is a stress hormone that can be measured in saliva. This has provided a convenient way to evaluate the biological impact of day-to-day stressors that people encounter as they go about their lives, since saliva is so easy to collect. However, the biological meaning of saliva cortisol measures has never been carefully examined. The goal of this study is to collect saliva from a large group of people as they go about their every-day lives, to measure their cortisol levels, and then study them in the laboratory where Investigators can learn more about how their stress response system (which produces cortisol) is really functioning. Investigators can then determine much more precisely what saliva cortisol levels really mean in terms of stress system biology. This will allow investigators to obtain much more useful information from the next decade of research on naturalistic stress and its biological impact using saliva cortisol measures, helping investigators to understand how stress undermines health and how to combat this effect.
Conditions
- Stress
Interventions
- DRUG
-
Metyrapone
750 mcg, oral, administered twice, 3.5 hours apart
- DRUG
-
Administered twice: 1.5 mg, oral, at 11 pm And 0.25 mg, oral, at bedtime at least one week before or after other administration.
- DRUG
-
Cortrosyn
250 mcg, IV, bolus, in the afternoon.
- DRUG
-
Corticorelin ovine triflutate
100 mcg, IV, over 30 seconds, in the afternoon.
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
James L Abelson, MD · University of Michigan
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-10-31
- Primary Completion
- 2017-08-15
- Completion
- 2017-08-15
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Liquorice and Salivary Cortisol
NCT04045015 ·Status: UNKNOWN ·Phase: NA
-
Discriminant Capacity and Thresholds of Salivary Cortisol in Chemiluminescence in the Diagnosis of Hypercorticisms
NCT03974789 ·Status: ACTIVE_NOT_RECRUITING
-
Evaluation of Emotion-related Salivary Molecular Biomarkers
NCT07320040 ·Status: RECRUITING
-
Assessment of Diurnal Salivary Cortisol Production in COVID-19
NCT04988269 ·Status: COMPLETED
-
Biomarkers in Saliva and Stool
NCT03297008 ·Status: TERMINATED
-
Noninvasive Biomarkers for Monitoring Cardiometabolic Risk in Children
NCT01465789 ·Status: TERMINATED
-
Efficacy Study of Zeller Entspannung Film Coated Tablets on Acute Stress
NCT02189239 ·Status: COMPLETED ·Phase: PHASE4
-
Examining Stress Salivary Biomarkers in Pediatric Patients Undergoing Dental Procedures
NCT06730425 ·Status: COMPLETED
-
Salivary Proteins in Disease and Health
NCT00100204 ·Status: COMPLETED
-
Measurements of Water in Breath and Saliva
NCT03233256 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Establishment and Clinical Application of Reference Intervals of Salivary Cortisol
NCT07168122 ·Status: RECRUITING
-
Neonatal, Infant and Toddler Salivary Study (NITS Study)
NCT05350982 ·Status: COMPLETED
-
Use of Saliva for COVID-19 Diagnosis
NCT04953039 ·Status: COMPLETED
-
The Functioning of Immune and Hormonal Systems in Patients With Sjogren's Syndrome and in Healthy Volunteers
NCT00001953 ·Status: COMPLETED
-
Matrix Metalloproteinases's in Oral Biofluids During Pregnancy and Postpartum
NCT03516565 ·Status: COMPLETED
-
An Evaluation of the Impact of a Single Dose of P-552 on Oral Mucosal Wetness
NCT01369589 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Endocrine Disruptors in Saliva Released From Bruxism Splints.
NCT06088238 ·Status: UNKNOWN
-
An Investigation Into the Effect of Liquorice Ingestion on the Salivary Cortisol to Cortisone Molar Ratio
NCT02939144 ·Status: COMPLETED ·Phase: NA
-
Dexamethasone Irrigation of the Parotid Glands in Primary Sjögren's Syndrome Subjects
NCT01316770 ·Status: TERMINATED ·Phase: PHASE2
-
Effect of Octreotide on Saliva
NCT05340192 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability of Infacort When Administered Onto Food Compared to Direct Oral Administration
NCT03178214 ·Status: COMPLETED ·Phase: PHASE1
-
Contribution of Salivary Cortisol in the Detection of Infra-clinic Cortisol Adenoma (ACIC)
NCT01156519 ·Status: TERMINATED ·Phase: NA
-
Potential of an Experimental Mouthwash Formulation to Reduce Dry Mouth Symptoms
NCT02641912 ·Status: COMPLETED ·Phase: NA
-
Development of a Molecular Diagnostic Strategy for SARS-CoV2 Based on Saliva in the Context of the COVID-19 Pandemic
NCT04367545 ·Status: COMPLETED ·Phase: NA
-
Clinical Study of the Effect of Two Experimental Lozenges on Oral Malodor After Single Use
NCT05950529 ·Status: COMPLETED ·Phase: NA